Cathepsin D expression in skin metastasis of breast cancer

Journal of Cutaneous Pathology

Volumn 25, Issue 7, 1998, Pages 365-369

  Inoue, Hiroyoshi ^a   Kawada, Akira ^b   Takasu, Hiroshi ^a   Maruyama, Ryuji ^c   Hata, Yasuki ^d   Hiruma, Masataro ^a   Tajima, Shingo ^a   Ishibashi, Akira ^a  

^a NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

^b TEIKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^d KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARTIC PROTEINASE; CARCINOEMBRYONIC ANTIGEN; CATHEPSIN B; CATHEPSIN D; ESTROGEN RECEPTOR; MONOCLONAL ANTIBODY; ONCOPROTEIN;

ADULT; ARTICLE; BREAST CANCER; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOPLASM; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOLOGY; LARGE CELL CARCINOMA; LUNG CANCER; MALE; PROTEIN EXPRESSION; SKIN METASTASIS; SQUAMOUS CELL CARCINOMA; STOMACH CANCER; SWEAT GLAND;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CATHEPSIN D; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; SKIN NEOPLASMS; STOMACH NEOPLASMS; SWEAT GLAND NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 0031697519     PISSN: 03036987     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0560.1998.tb01759.x     Document Type: Article

References (26)

1. McLean DI, Haynes HA. Cutaneous manifestations of internal malignant disease. In: Fitzpatrick TB, Eisen AZ, Wolff K, Freedberg IM, Austen KF, eds. Dermatology in general medicine (4th ed). New York: MrGraw-Hill, 1993: 2242.
2. Gatter KC, Alcock C, Heryet A, Mason DY. Clinical importance of analysing malignant tumours of uncertain origin with immunohistological techniques. Lancet 1985: 1: 1302.
3. Rochefort H. Biological and clinical significance of cathepsin D in breast cancer. Semin Cancer Biol 1990: 1: 153.
4. r 52000 cathepsin D secreted by breast cancer cells. Cancer Res 1988: 48: 3688.
5. Spyratos F, Maudelonde T, Brouillet JP, et al. Cathepsin D: An independent prognostic factor for metastasis of breast cancer. Lancet 1989: 2: 1115.
6. Higashiyama M, Doi O, Kodama K, Yokouchi H, Tateishi R. Cathepsin B expression in tumour cells and laminin distribution in pulmonary adenocarcinoma. J Clin Pathol 1993: 46: 18.
7. Castiglioni T, Merino MJ, Elsner B, Lah TT, Sloane BF, Emmert-Buck MR. Immunohistochemical analysis of cathepsins D, B, and L in human breast cancer. Hum Pathol 1994: 25: 857.
8. Penneys NS, Nadji M, McKinney EC. Carcinoembryonic antigen is present in human eccrice sweat. J Am Acad Dermatol 1981: 4: 401.
9. Sundblad AS, Pellicer EM, Ricci L. Carcinoembryonic antigen expression in stages I and II breast cancer: Its relationship with clinicopathologic factors. Hum Pathol 1996: 27: 297.
10. Esteban JM, Felder B, Ahn C, Simpson JF, Battifora H, Shively JE. Prognostic relevance of carcinoembryonic antigen and estrogen receptor status in breast cancer patients. Cancer 1994: 74: 1575.
11. Mazoujian G, Pinkus GS, Dayis S, Haagensen DE. Immunohistochemistry of a gross cystic disease fluid protein (GCDFP-15) of the breast. A marker of apocrine epithelium and breast carcinomas with apocrine features. Am J Pathol 1983: 110: 105.
12. Ormsby AH, Snow JL, Daniel Su WP, Goellner JR. Diagnostic immunohistochemistry of cutaneous metastatic breast carcinoma: A statistical analysis of the utility of gross cystic disease fluid protein-15 and estrogen receptor protein. J Am Acad Dermatol 1995: 32: 711.
13. Sowa M, Chung Y-S, Kato Y, et al. An immunohistological study of breast cancer - with special reference to the expression of carbohydrate antigens and estrogen receptor status. Jpn J Surg 1990: 20: 252.
14. Maguire HC, Jaworsky C, Cohen JA, Hellman M, Weiner DB, Greene MI. Distribution of neu (c-erbB-2) protein in human skin. J Invest Dermatol 1989: 89: 786.
15. Hasebe T, Mukai K, Ishihara K, Kaneko A, Shimosato Y. Sebaceous gland and sweat gland carcinomas of the skin. Clinicopathological study and significance of c-erbB-2 oncoprotein expression. Acta Pathol Jpn 1992: 42: 585.
16. Terrier P, Mouriesse H, London B, Gotteland M, May-Levin F, Delarue J-C. Use of a polyclonal antibody for the determination of the prognostic value of c-erbB-2 protein over-expression in human breast cancer. Acta Oncol 1996: 35: 23.
17. Nakopoulou LL, Alexiadou A, Theodoropoulos GE, Lazaris AC, Tzonou A, Keramopoulos A. Prognostic significance of the co-expression of p53 and c-erbB-2 proteins in breast cancer. J Pathol 1996: 179: 31.
18. Winstanley J, Cooke T, Murray GD, et al. The long term prognostic significance of c-erbB-2 in primary breast cancer. Br J Cancer 1991: 63: 447.
19. Abrams HL, Spiro R, Goldstein N. Metastases in carcinoma. Analysis of 1000 autopsied cases. Cancer 1950: 3: 74.
20. Gates O. Cutaneous metastases of malignant disease. Am J Cancer 1937: 30: 718.
21. Mackie RM. Soft tissue tumours. In: Champion RH, Burton JL, Ebling FJG, eds: ROOK/ WILKINSON/ EBLING Textbook of Dermatology (5th ed). Oxford: Blackwell Scientific Publications, 1992: 2099.
22. Beerman H. Some aspects of cutaneous malignancy. Am J Med Sci 1957: 233: 456.
23. Connor DH, Taylor HB, Helwig EB. Cutaneous metastasis of renal cell carcinoma. Arch Pathol 1963: 76: 339.
24. Capony F, Rougeot C, Montcourrier P, Cavailles V, Salazar G, Rochefort H. Increased secretion, altered processing, and glycosylation of pro-cathepsin D in human mammary cancer cells. Cancer Res 1989: 49: 3904.
25. Henry JA, McCarthy AL, Angus B, et al. Prognostic significance of the estrogen-regulated protein, cathepsin D, in breast cancer. An immunohistochemical study. Cancer 1990: 65: 265.
26. Cooke T, George D, Shields R, Maynard P, Griffiths K. estrogen receptors and prognosis in early breast cancer. Lancet 1979: 1: 995.